HNF4A and breast carcinoma: SSA, like SS, was shown to inhibit cGMP PDE activity, raise intracellular levels of cGMP, activate PKG, and reduce Tcf transcriptional activity at concentrations that correlated with its ability to inhibit growth and to induce apoptosis of human breast cancer cells, adding further evidence of this COX-independent antineoplastic mechanism.